Table 2.
Predisposing factor | No. of isolates (% for each predisposing factor) |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Totala | C. albicans | C. parapsilosis | C. tropicalis | C. glabrata | C. guilliermondii | C. lusitaniae | C. krusei | C. famata | R. glutinis | T. asahii | |
Intravascular line | 161 (79.3) | 62 (38.5) | 73 (45.3) | 10 (6.2) | 5 (3.1) | 3 (1.9) | 3 (1.9) | 2 (1.2) | 1 (0.6) | 1 (0.6) | 1 (0.6) |
Surgery | 70 (35.0) | 29 (41.4) | 34 (48.6) | 3 (4.3) | 4 (5.7) | ||||||
Prematurity | 60 (30.0) | 33 (55.0) | 22 (36.7) | 2 (3.3) | 1 (1.7) | 1 (1.7) | 1 (1.7) | 1 (1.7) | |||
Neutropenia | 22 (11.0) | 10 (45.4) | 4 (18.2) | 4 (18.2) | 1 (4.5) | 1 (4.5) | 2 (9.0) | ||||
HSCT | 18 (9.0) | 4 (22.2) | 9 (50.0) | 4 (22.2) | 1 (5.5) | ||||||
Burns | 5 (2.5) | 2 (40.0) | 3 (60.0) | ||||||||
SOT | 4 (2.0) | 2 (50.0) | 1 (25.0) | 1 (25.0) | |||||||
HIV | 1 (0.5) | 1 (100) |
Some patients have more than one risk factor. HSCT, hematopoietic stem cell transplant; SOT, solid organ transplant.